Health needs, drug registration and control in less developed countries--the Peruvian case.
A number of factors influence how medicines are used in each community, but drug registration is the initial and usually necessary step. In the course of an external advisory consultation, the list of approved medicines in Peru in 1998 was examined. Of 1672 newly approved forms, 119 were of 49 new chemical entities. Sildenafil, meloxicam, nimesulide, candesartan, irebesartan, naratriptan, trovafloxacin and grepafloxacin were among them. Several aspects about the new global drug situation and 'real' health needs versus 'induced' health needs are discussed from this example.
Figueras
Albert
A
Fundació Institut Català de Farmacologia, WHO Collaborating Centre for Research & Training in Pharmacoepidemiology, Universitat Autònoma de Barcelona, Hospitals Vall d'Hebron, 08035-Barcelona, Spain. afs@icf.uab.es
Vasquez
Susana
S
Arnau
Josep-Maria
JM
Laporte
Joan-Ramon
JR
D003906:Developing Countries / Q000706:statistics & numerical data*; D017277:Drug Approval / Q000379:methods / Q000706:statistics & numerical data*; D017723:Drug Utilization Review; D006301:Health Services Needs and Demand / Q000706:statistics & numerical data*; D006801:Humans; D020380:Needs Assessment; D010568:Peru; D017891:Pharmacoepidemiology / Q000706:statistics & numerical data; D018570:Risk Assessment